<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- EDGAR Online I-Metrix Xcelerate Instance Document, based on XBRL 2.1  http://www.edgar-online.com/ -->
<!-- Version:  6.12.8 -->
<!-- Round: dce48d1e-9a52-4137-8edf-8dacacab9a69 -->
<!-- Creation date: 2011-08-09T16:44:03Z -->
<!-- Copyright (c) 2005-2011 EDGAR Online, Inc. All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2011-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:hae="http://www.haemonetics.com/20110702" xmlns:invest="http://xbrl.sec.gov/invest/2011-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="hae-20110702.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20100703_0" unitRef="iso4217_USD" decimals="-3">8107000</us-gaap:RestructuringReserve>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0006_STD_0_20100703_0" unitRef="iso4217_USD" decimals="-3">879000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0006_STD_0_20100703_0" unitRef="iso4217_USD" decimals="-3">83467000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20100703_0_450737x445456" unitRef="iso4217_USD" decimals="-3">8107000</us-gaap:RestructuringReserve>
  <us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice contextRef="eol_PE5753----1110-Q0006_STD_0_20101228_0_452537x478695" unitRef="iso4217_USD" decimals="-5">6400000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityPurchasePrice>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="shares" decimals="INF">25770869</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_22">10203000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">3707000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DeferredTaxAssetsNetCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_6">9930000</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_46">11539000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_33">103019000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_21">1357000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-5">144400000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
  <us-gaap:LongTermDebtNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_34">3606000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">2230000</us-gaap:RestructuringReserve>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_45">390577000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_7">25729000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">2475000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">1259000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_3">120759000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:Assets contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_24">853406000</us-gaap:Assets>
  <us-gaap:AccruedIncomeTaxesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_30">6082000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_39">257000</us-gaap:CommonStockValue>
  <us-gaap:InventoryNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_5">94960000</us-gaap:InventoryNet>
  <us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0">1Y</us-gaap:AverageRemainingMaturityOfForeignCurrencyDerivatives>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" xsi:nil="true" id="fnid_24337065_1_37" />
  <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-5">10800000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
  <us-gaap:OtherLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_32">44321000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="shares" decimals="INF" id="fnid_24337065_1_43">25770869</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:MachineryAndEquipmentGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_11">132404000</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:AssetsCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_8">468269000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_31">554000</us-gaap:DeferredTaxLiabilitiesCurrent>
  <us-gaap:Goodwill contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_20">115707000</us-gaap:Goodwill>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_19">46707000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_36">15939000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:InventoryFinishedGoods contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">59397000</us-gaap:InventoryFinishedGoods>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_2">216891000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD_per_shares" decimals="2" id="fnid_24337065_1_40">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_4">1741000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_35">18386000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_14">485118000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_15">328140000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:InventoryRawMaterials contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">30368000</us-gaap:InventoryRawMaterials>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_48">853406000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_44">310083000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:StockholdersEquity contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_47">712456000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="shares" decimals="INF" id="fnid_24337065_1_42">25770869</us-gaap:CommonStockSharesIssued>
  <us-gaap:PropertyPlantAndEquipmentOther contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_13">215640000</us-gaap:PropertyPlantAndEquipmentOther>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_18">100892000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_16">156978000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:LongTermDebtCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_27">906000</us-gaap:LongTermDebtCurrent>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="shares" decimals="INF" id="fnid_24337065_1_41">150000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:InventoryWorkInProcess contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3">5195000</us-gaap:InventoryWorkInProcess>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_28">28155000</us-gaap:AccountsPayableCurrent>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-5">47300000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_29">23001000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:LongTermDebtFairValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-5">3900000</us-gaap:LongTermDebtFairValue>
  <hae:TotalOtherAssets contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_23">228159000</hae:TotalOtherAssets>
  <hae:OfficeEquipmentAndInformationTechnologyGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_12">84530000</hae:OfficeEquipmentAndInformationTechnologyGross>
  <hae:LandBuildingsAndBuildingImprovementsGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0" unitRef="iso4217_USD" decimals="-3" id="fnid_24337065_1_10">52544000</hae:LandBuildingsAndBuildingImprovementsGross>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_441306x451457_451532x449846_452742x467802" unitRef="iso4217_USD" decimals="-3">2475000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_441306x451457_451532x449846_452742x468536" unitRef="iso4217_USD" decimals="-3">3707000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">2475000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">173298000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">2338000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">6045000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">3707000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">170823000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">2338000</us-gaap:OtherLiabilitiesFairValueDisclosure>
  <us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">2475000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">2475000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">3707000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x441954" unitRef="iso4217_USD" decimals="-3">3707000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x452604" unitRef="iso4217_USD" decimals="-3">170823000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:InvestmentsFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x452604" unitRef="iso4217_USD" decimals="-3">170823000</us-gaap:InvestmentsFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x454206" unitRef="iso4217_USD" decimals="-3">2338000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:OtherLiabilitiesFairValueDisclosure contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x454206" unitRef="iso4217_USD" decimals="-3">2338000</us-gaap:OtherLiabilitiesFairValueDisclosure>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450737x445456" unitRef="iso4217_USD" decimals="-3">1483000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_450737x447194" unitRef="iso4217_USD" decimals="-3">747000</us-gaap:RestructuringReserve>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_452537x478695" unitRef="iso4217_USD" decimals="-5">600000</us-gaap:BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_452537x478695" unitRef="iso4217_USD" decimals="-5">2700000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillAmount>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets contextRef="eol_PE5753----1110-Q0006_STD_0_20110702_0_452537x478695" unitRef="iso4217_USD" decimals="-5">4300000</us-gaap:BusinessAcquisitionPurchasePriceAllocationAmortizableIntangibleAssets>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20100403_0" unitRef="iso4217_USD" decimals="-3">9761000</us-gaap:RestructuringReserve>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0006_STD_0_20100403_0" unitRef="iso4217_USD" decimals="-3">903000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0006_STD_0_20100403_0" unitRef="iso4217_USD" decimals="-3">141562000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20100403_0_450737x445456" unitRef="iso4217_USD" decimals="-3">9761000</us-gaap:RestructuringReserve>
  <us-gaap:OtherAssetsNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">10458000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">4174000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DeferredTaxAssetsNetCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">9674000</us-gaap:DeferredTaxAssetsNetCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">9541000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:LiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">108671000</us-gaap:LiabilitiesCurrent>
  <us-gaap:DeferredTaxAssetsNetNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">1291000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">154800000</us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet>
  <us-gaap:LongTermDebtNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">3966000</us-gaap:LongTermDebtNoncurrent>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">3671000</us-gaap:RestructuringReserve>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">373630000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">30897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">2563000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:ProductWarrantyAccrual contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">1273000</us-gaap:ProductWarrantyAccrual>
  <us-gaap:AccountsReceivableNetCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">127166000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:Assets contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">833264000</us-gaap:Assets>
  <us-gaap:AccruedIncomeTaxesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">6033000</us-gaap:AccruedIncomeTaxesCurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">256000</us-gaap:CommonStockValue>
  <us-gaap:InventoryNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">84387000</us-gaap:InventoryNet>
  <us-gaap:CommitmentsAndContingencies contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">13400000</us-gaap:CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers>
  <us-gaap:OtherLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">46256000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="shares" decimals="INF">25660393</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:MachineryAndEquipmentGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">128612000</us-gaap:MachineryAndEquipmentGross>
  <us-gaap:AssetsCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">448831000</us-gaap:AssetsCurrent>
  <us-gaap:DeferredTaxLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">107000</us-gaap:DeferredTaxLiabilitiesCurrent>
  <us-gaap:Goodwill contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">115367000</us-gaap:Goodwill>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">43827000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">15822000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:InventoryFinishedGoods contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">53631000</us-gaap:InventoryFinishedGoods>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">196707000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD_per_shares" decimals="2">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">1799000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
  <us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">18669000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <us-gaap:PropertyPlantAndEquipmentGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">475684000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">320156000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:InventoryRawMaterials contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">26404000</us-gaap:InventoryRawMaterials>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">833264000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">302709000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:StockholdersEquity contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">686136000</us-gaap:StockholdersEquity>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="shares" decimals="INF">25660393</us-gaap:CommonStockSharesIssued>
  <us-gaap:PropertyPlantAndEquipmentOther contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">211455000</us-gaap:PropertyPlantAndEquipmentOther>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">101789000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">155528000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:LongTermDebtCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">913000</us-gaap:LongTermDebtCurrent>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="shares" decimals="INF">150000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:InventoryWorkInProcess contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">4352000</us-gaap:InventoryWorkInProcess>
  <us-gaap:AccountsPayableCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">28323000</us-gaap:AccountsPayableCurrent>
  <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">45900000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAtFairValueNet>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">27039000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:LongTermDebtFairValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-5">4100000</us-gaap:LongTermDebtFairValue>
  <hae:TotalOtherAssets contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">228905000</hae:TotalOtherAssets>
  <hae:OfficeEquipmentAndInformationTechnologyGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">83258000</hae:OfficeEquipmentAndInformationTechnologyGross>
  <hae:LandBuildingsAndBuildingImprovementsGross contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0" unitRef="iso4217_USD" decimals="-3">52359000</hae:LandBuildingsAndBuildingImprovementsGross>
  <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0_441306x451457_451532x449846_452742x467802" unitRef="iso4217_USD" decimals="-3">2563000</us-gaap:DerivativeFairValueOfDerivativeAsset>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0_441306x451457_451532x449846_452742x468536" unitRef="iso4217_USD" decimals="-3">4174000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0_450407x454319" unitRef="iso4217_USD" decimals="-3">2284000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0_450737x445456" unitRef="iso4217_USD" decimals="-3">2782000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="eol_PE5753----1110-Q0006_STD_0_20110402_0_450737x447194" unitRef="iso4217_USD" decimals="-3">889000</us-gaap:RestructuringReserve>
  <us-gaap:GrossProfit contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">86463000</us-gaap:GrossProfit>
  <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">50000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">3010000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">111000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-15113000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">102000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">237000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-655000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:ProductWarrantyAccrualPayments contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">459000</us-gaap:ProductWarrantyAccrualPayments>
  <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-5">1200000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
  <us-gaap:CostOfGoodsSold contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">76576000</us-gaap:CostOfGoodsSold>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-4247000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="pure" decimals="4">0.0264</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">13526000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="shares" decimals="INF">35992</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">14041000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">1645000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">24375000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">2197000</us-gaap:ShareBasedCompensation>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD_per_shares" decimals="2">0.70</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-19078000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">1650000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">15000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:InterestExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">153000</us-gaap:InterestExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">450000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">205000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD_per_shares" decimals="2">17.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">17918000</us-gaap:NetIncomeLoss>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">1245000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">7920000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">549000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-165000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-5">2200000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="shares" decimals="-5">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">435000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">15224000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD_per_shares" decimals="2">0.71</us-gaap:EarningsPerShareBasic>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">12410000</us-gaap:DepreciationAndAmortization>
  <us-gaap:TaxBenefitFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">538000</us-gaap:TaxBenefitFromStockOptionsExercised>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">24189000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestPaidNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">128000</us-gaap:InterestPaidNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">163039000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-9936000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">49000</us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax>
  <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-5">500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
  <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-6617000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="Year" decimals="1">5.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">4591000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">54354000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">6457000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-58095000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="shares" decimals="-3">25140000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-1571000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">31000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">4167000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:OperatingExpenses contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">62274000</us-gaap:OperatingExpenses>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="pure" decimals="3">0.265</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-877000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="shares" decimals="-3">25703000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">-54937000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-5">800000</us-gaap:IncomeTaxReconciliationTaxContingencies>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">2899000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="pure" decimals="4">0.2834</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="shares" decimals="-3">563000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <hae:TransfersFromInventoryToFixedAssets contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD" decimals="-3">1091000</hae:TransfersFromInventoryToFixedAssets>
  <hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0" unitRef="iso4217_USD_per_shares" decimals="2">45.70</hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare>
  <us-gaap:CashFlowHedgeLossReclassifiedToEarnings contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_441306x451457_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-5">900000</us-gaap:CashFlowHedgeLossReclassifiedToEarnings>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x450145" unitRef="iso4217_USD" decimals="-3">133564000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x472622" unitRef="iso4217_USD" decimals="-3">13015000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478709" unitRef="iso4217_USD" decimals="-3">55917000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478711" unitRef="iso4217_USD" decimals="-3">47631000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478711_456277x478706" unitRef="iso4217_USD" decimals="-3">36317000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478711_456277x478707" unitRef="iso4217_USD" decimals="-3">11314000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712" unitRef="iso4217_USD" decimals="-3">30016000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712_456277x478708" unitRef="iso4217_USD" decimals="-3">16351000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712_456277x478714" unitRef="iso4217_USD" decimals="-3">4708000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712_456277x478715" unitRef="iso4217_USD" decimals="-3">8957000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478713" unitRef="iso4217_USD" decimals="-3">16460000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_450737x445456" unitRef="iso4217_USD" decimals="-3">1245000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_450737x445456" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0006_STD_91_20100703_0_450737x445456" unitRef="iso4217_USD" decimals="-3">2899000</us-gaap:RestructuringReserveSettledWithCash>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">Q1</dei:DocumentFiscalPeriodFocus>
  <dei:TradingSymbol contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">HAE</dei:TradingSymbol>
  <dei:EntityRegistrantName contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">HAEMONETICS CORP</dei:EntityRegistrantName>
  <dei:AmendmentFlag contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">false</dei:AmendmentFlag>
  <dei:EntityFilerCategory contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentType contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">10-Q</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">2011-07-02</dei:DocumentPeriodEndDate>
  <dei:EntityCentralIndexKey contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">0000313143</dei:EntityCentralIndexKey>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">--03-31</dei:CurrentFiscalYearEndDate>
  <us-gaap:GrossProfit contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">88748000</us-gaap:GrossProfit>
  <us-gaap:ProceedsFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">2675000</us-gaap:ProceedsFromStockOptionsExercised>
  <us-gaap:ProductWarrantyDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;5.
PRODUCT WARRANTIES&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
generally provide a warranty on parts and labor for one year after
the sale and installation of each device. We also warrant our
disposables products through their use or expiration. We estimate
our potential warranty expense based on our historical warranty
experience, and we periodically assess the adequacy of our warranty
accrual and make adjustments as necessary.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;For the three months ended&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the beginning of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,273&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;903&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
provision&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;278&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;435&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
spending&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(292&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(459&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the end of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,259&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;879&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
  <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">19000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
  <us-gaap:CapitalizedComputerSoftwareAdditions contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-5">4100000</us-gaap:CapitalizedComputerSoftwareAdditions>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-11782000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:InvestmentIncomeInterest contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">106000</us-gaap:InvestmentIncomeInterest>
  <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table presents the effect of our derivative instruments
designated as cash flow hedges and those not designated as hedging
instruments under ASC Topic 815 in our consolidated statement of
income for the three months ended July&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="40%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount of Loss&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount of Loss&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Reclassified&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Recognized&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;from AOCI into&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Excluded from&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;in AOCI&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Earnings&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Effectiveness&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;Derivative Instruments&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Testing (*)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2"&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,323&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,637&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Net revenues,&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(41&lt;/td&gt;
&lt;td&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap"&gt;Other income&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;COGS, and&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;SG&amp;amp;A&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Non-designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;591&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other expense&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="7" align="left"&gt;
&amp;#xA0; &amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,323&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,637&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;550&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="7" align="left"&gt;&amp;#xA0; &amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left"&gt;
&lt;div style="MARGIN-TOP: 16pt; WIDTH: 18%; FONT-SIZE: 3pt; BORDER-TOP: #000000 1px solid"&gt;
&amp;#xA0;&lt;/div&gt;
&lt;/div&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="3%"&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&lt;/td&gt;
&lt;td width="96%"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="top"&gt;
&lt;td nowrap="nowrap" align="left"&gt;(*)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;We exclude the difference between the spot rate and hedge
forward rate from our effectiveness testing.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
  <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
Revenues from External Customers:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Disposable
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Plasma
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;62,759&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;55,917&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Blood center
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;Platelet&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;37,310&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;36,317&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;Red cell&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,869&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,314&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;49,178&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;47,631&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Hospital
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;Surgical&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;15,742&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,351&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;OrthoPAT&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;7,754&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;8,957&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;
Diagnostics&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5,615&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,708&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;29,111&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;30,016&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Disposables
revenue&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;141,048&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;133,564&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Software
solutions&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;18,160&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,460&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Equipment &amp;amp;
other&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,361&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;13,015&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,569&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;163,039&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-215000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-7939000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:ProductWarrantyAccrualPayments contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">292000</us-gaap:ProductWarrantyAccrualPayments>
  <us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-5">1500000</us-gaap:ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost>
  <us-gaap:CostOfGoodsSold contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">81821000</us-gaap:CostOfGoodsSold>
  <us-gaap:DerivativesAndFairValueTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;9.
DERIVATIVES AND&lt;/b&gt; &lt;font style="FONT-VARIANT: small-caps"&gt;&lt;b&gt;FAIR
VALUE MEASUREMENTS&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
manufacture, market and sell our products globally. Approximately
49% of our sales were generated outside the U.S. in local
currencies. We also incur certain manufacturing, marketing and
selling costs in international markets in local currency.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Accordingly, our earnings and cash flows are exposed to market risk
from changes in foreign currency exchange rates relative to the
U.S. dollar, our reporting currency.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We have
a program in place that is designed to mitigate our exposure to
changes in foreign currency exchange rates. That program includes
the use of derivative financial instruments to minimize for a
period of time, the unforeseen impact on our financial results from
changes in foreign exchange rates. We utilize forward foreign
currency contracts to hedge the anticipated cash flows from
transactions denominated in foreign currencies, primarily the
Japanese Yen and the Euro, and to a lesser extent the Swiss Franc,
British Pound Sterling and the Canadian Dollar. This does not
eliminate the volatility of foreign exchange rates, but because we
generally enter into forward contracts one year out, rates are
fixed for a one-year period, thereby facilitating financial
planning and resource allocation.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Designated Foreign Currency Hedge Contracts&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;All of
our designated foreign currency hedge contracts as of July&amp;#xA0;2,
2011 and April&amp;#xA0;2, 2011 were cash flow hedges under ASC Topic
815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. We record the effective
portion of any change in the fair value of designated foreign
currency hedge contracts in Accumulated Other Comprehensive Income
in Stockholders&amp;#x2019; Equity until the related third-party
transaction occurs. Once the related third-party transaction
occurs, we reclassify the effective portion of any related gain or
loss on the designated foreign currency hedge contracts to
earnings. In the event the hedged forecasted transaction does not
occur, or it becomes probable that it will not occur, we would
reclassify the amount of any gain or loss on the related cash flow
hedge to earnings at that time. We had designated foreign currency
hedge contracts outstanding in the contract amount of
$144.4&amp;#xA0;million as of July&amp;#xA0;2, 2011 and $154.8&amp;#xA0;million
as of April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;During
the quarter ended July&amp;#xA0;2, 2011, we recognized net losses of
$1.6&amp;#xA0;million in earnings on our cash flow hedges. All currency
cash flow hedges outstanding as of July&amp;#xA0;2, 2011 mature within
twelve months. For the quarter ended July&amp;#xA0;2, 2011, net losses
of $0.6&amp;#xA0;million were recorded in Accumulated Other
Comprehensive Income to recognize the effective portion of the fair
value of any designated foreign currency hedge contracts that are,
or previously were, designated as foreign currency cash flow
hedges, as compared to net losses of $0.9&amp;#xA0;million as of
July&amp;#xA0;3, 2010. At July 2, 2011, $1.3&amp;#xA0;million of losses,
net of tax, may be reclassified to earnings within the next twelve
months.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Non-designated Foreign Currency Hedge Contracts&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
manage our exposure to changes in foreign currency on a
consolidated basis to take advantage of offsetting transactions and
balances. We use currency forward contracts as a part of our
strategy to manage exposure related to foreign currency denominated
monetary assets and liabilities. These currency forward contracts
are not designated as cash flow or fair value hedges under ASC
Topic 815. These forward contracts are marked-to-market with
changes in fair value recorded to earnings; and are entered into
for periods consistent with currency transaction exposures,
generally one month. We had non-designated foreign currency hedge
contracts under ASC Topic 815 outstanding in the contract amount of
$47.3&amp;#xA0;million as of July&amp;#xA0;2, 2011 and $45.9&amp;#xA0;million
as of April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;&lt;u&gt;Fair
Value of Derivative Instruments&lt;/u&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table presents the effect of our derivative instruments
designated as cash flow hedges and those not designated as hedging
instruments under ASC Topic 815 in our consolidated statement of
income for the three months ended July&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="40%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount of Loss&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount of Loss&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Reclassified&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Amount&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Recognized&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;from AOCI into&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Excluded from&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;in AOCI&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Earnings&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Effectiveness&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Statement of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;Derivative Instruments&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Effective Portion)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Testing (*)&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Operations&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2"&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,323&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,637&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Net revenues,&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(41&lt;/td&gt;
&lt;td&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap"&gt;Other income&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;COGS, and&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" align="center"&gt;SG&amp;amp;A&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&lt;/td&gt;
&lt;td valign="top" align="right"&gt;&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Non-designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;591&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other expense&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="7" align="left"&gt;
&amp;#xA0; &amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,323&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,637&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;550&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="7" align="left"&gt;&amp;#xA0; &amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left"&gt;
&lt;div style="MARGIN-TOP: 16pt; WIDTH: 18%; FONT-SIZE: 3pt; BORDER-TOP: #000000 1px solid"&gt;
&amp;#xA0;&lt;/div&gt;
&lt;/div&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr&gt;
&lt;td width="3%"&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&lt;/td&gt;
&lt;td width="96%"&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="top"&gt;
&lt;td nowrap="nowrap" align="left"&gt;(*)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;We exclude the difference between the spot rate and hedge
forward rate from our effectiveness testing.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We did
not have fair value hedges or net investment hedges outstanding as
of July&amp;#xA0;2, 2011 or April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;ASC
Topic 815 requires all derivative instruments to be recognized at
their fair values as either assets or liabilities on the balance
sheet. We determine the fair value of our derivative instruments
using the framework prescribed by ASC Topic 820, &lt;i&gt;Fair Value
Measurements and Disclosures&lt;/i&gt;, by considering the estimated
amount we would receive or pay to sell or transfer these
instruments at the reporting date and by taking into account
current interest rates, currency exchange rates, the
creditworthiness of the counterparty for assets, and our
creditworthiness for liabilities. In certain instances, we may
utilize financial models to measure fair value. Generally, we use
inputs that include quoted prices for similar assets or liabilities
in active markets; quoted prices for identical or similar assets or
liabilities in markets that are not active; other observable inputs
for the asset or liability; and inputs derived principally from, or
corroborated by, observable market data by correlation or other
means. As of July&amp;#xA0;2, 2011, we have classified our derivative
assets and liabilities within Level 2 of the fair value hierarchy
prescribed by ASC Topic 815, as discussed below, because these
observable inputs are available for substantially the full term of
our derivative instruments.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;The
following tables present the fair value of our derivative
instruments as they appear in our consolidated balance sheet as of
July&amp;#xA0;2, 2011 and April&amp;#xA0;2, 2011 by type of contract and
whether it is a qualifying hedge under ASC Topic 815.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="64%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Balance Sheet&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Assets:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other current
assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;2,475&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;2,563&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Liabilities:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other accrued
liabilities&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,174&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;3,707&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;4,174&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;&lt;u&gt;Other
Fair Value Measurements&lt;/u&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;ASC
Topic 820, &lt;i&gt;Fair Value Measurements and Disclosures&lt;/i&gt; defines
fair value, establishes a framework for measuring fair value in
accordance with U.S. GAAP, and expands disclosures about fair value
measurements. ASC Topic 820 does not require any new fair value
measurements; rather, it applies to other accounting pronouncements
that require or permit fair value measurements. In accordance with
ASC Topic 820, for the three months ended July&amp;#xA0;2, 2011, we
applied the requirements under ASC Topic 820 to our non-financial
assets and non-financial liabilities. As we did not have an
impairment of any non-financial assets or non-financial
liabilities, there was no disclosure required relating to our
non-financial assets or non-financial liabilities.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;On a
recurring basis, we measure certain financial assets and financial
liabilities at fair value, including our money market funds,
foreign currency derivative contracts, and contingent
consideration. ASC Topic 820 defines fair value as the price that
would be received to sell an asset or paid to transfer a liability
in an orderly transaction between market participants at the
measurement date. As such, fair value is a market-based measurement
that should be determined based on assumptions that market
participants would use in pricing an asset or liability. We base
fair value upon quoted market prices, where available. Where quoted
market prices or other observable inputs are not available, we
apply valuation techniques to estimate fair value.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;ASC
Topic 820 establishes a three-level valuation hierarchy for
disclosure of fair value measurements. The categorization of assets
and liabilities within the valuation hierarchy is based upon the
lowest level of input that is significant to the measurement of
fair value. The three levels of the hierarchy are defined as
follows:&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr style="BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; FONT-SIZE: 10pt" valign="top"&gt;
&lt;td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%" nowrap="nowrap" align="left"&gt;&lt;b&gt;&amp;#x2022;&lt;/b&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;Level 1 &amp;#x2014; Inputs to the valuation methodology are quoted
market prices for identical assets or liabilities.&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="FONT-SIZE: 6pt"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; FONT-SIZE: 10pt" valign="top"&gt;
&lt;td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%" nowrap="nowrap" align="left"&gt;&lt;b&gt;&amp;#x2022;&lt;/b&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;Level 2 &amp;#x2014; Inputs to the valuation methodology are other
observable inputs, including quoted market prices for similar
assets or liabilities and market-corroborated inputs.&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="FONT-SIZE: 6pt"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; FONT-SIZE: 10pt" valign="top"&gt;
&lt;td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%" nowrap="nowrap" align="left"&gt;&lt;b&gt;&amp;#x2022;&lt;/b&gt;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;Level 3 &amp;#x2014; Inputs to the valuation methodology are
unobservable inputs based on management&amp;#x2019;s best estimate of
inputs market participants would use in pricing the asset or
liability at the measurement date, including assumptions about
risk.&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Our
money market funds carried at fair value are classified within
Level 1 of the fair value hierarchy because they are valued using
quoted market prices.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
recognize all derivative financial instruments in our consolidated
financial statements at fair value in accordance with ASC Topic
815, &lt;i&gt;Derivatives and Hedging&lt;/i&gt;. We determine the fair value of
these instruments using the framework prescribed by ASC Topic 820
by considering the estimated amount we would receive or pay to
terminate these agreements at the reporting date and by taking into
account current spot rates, the creditworthiness of the
counterparty for assets, and our creditworthiness for liabilities.
We have classified our foreign currency hedge contracts within
Level 2 of the fair value hierarchy because these observable inputs
are available for substantially the full term of our derivative
instruments. For the quarter ended July&amp;#xA0;2, 2011, we have
classified our other liabilities &amp;#x2014; contingent consideration
relating to our acquisition of Neoteric within Level 3 of the fair
value hierarchy because the value is determined using significant
unobservable inputs.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;i&gt;Fair
Value Measured on a Recurring Basis&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Financial assets and financial liabilities measured at fair value
on a recurring basis consist of the following as of July&amp;#xA0;2,
2011:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="36%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Quoted Market&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Prices for&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Observable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Unobservable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Identical
Assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;(Level 1)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;(Level 2)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;(Level 3)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;Total&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Assets&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Money market
funds&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,823&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,823&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Forward currency
exchange contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,823&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;173,298&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Liabilities&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Forward currency
exchange contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
liabilities &amp;#x2014; contingent consideration&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;6,045&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Level 3
liabilities consists of the contingent consideration liability that
is solely related to the Neoteric acquisition and is calculated
based on estimated annual revenue growth for the three years
following the acquisition at established profitability thresholds
and is not limited. The fair value of the liability is determined
using probability weighted projected revenues and earnings through
the ending in fiscal year 2012 that are discounted to present value
based on a risk-weighted expected rate of return. The table below
provides a reconciliation of the beginning and ending Level 3
liabilities for the three months ended July 2, 2011.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="88%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Fair Value&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Measurements&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Using
Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Unobservable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 3)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Beginning
balance&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,284&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Accretion of
interest expense on contingent consideration&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;89&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Change in
value&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(35&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Ending
balance&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Other Fair Value Disclosures&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The fair
value of our long-term debt obligations, which was estimated using
quoted market prices for the same or similar instruments, was
$3.9&amp;#xA0;million and $4.1&amp;#xA0;million at July&amp;#xA0;2, 2011 and
April&amp;#xA0;2, 2011, respectively.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">1705000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;b&gt;11&lt;/b&gt;&lt;font style="FONT-VARIANT: small-caps"&gt;&lt;b&gt;.
C&lt;/b&gt;&lt;/font&gt;&lt;b&gt;OMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We are
presently engaged in various legal actions, and although ultimate
liability cannot be determined at the present time, we believe,
based on consultation with counsel, that any such liability will
not materially affect our consolidated financial position or our
results of operations.&lt;/div&gt;
&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;b&gt;12&lt;/b&gt; &lt;font style="FONT-VARIANT: small-caps"&gt;&lt;b&gt;. SEGMENT
INFORMATION&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Segment Definition Criteria&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
manage our business on the basis of one operating segment: the
design, manufacture, and marketing of blood management solutions.
Our chief operating decision-maker uses consolidated results to
make operating and strategic decisions. Manufacturing processes, as
well as the regulatory environment in which we operate, are largely
the same for all product lines.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;i&gt;Enterprise Wide Disclosures about Product and Services&lt;/i&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We have
four global product families: plasma, blood center, hospital, and
software solutions.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Disposables (single-use sterile kits used in our devices for
collection or salvage of blood products) are marketed in our
plasma, blood center, and hospital product businesses. Plasma
disposables are used with our PCS&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"&gt;&amp;#xAE;&lt;/sup&gt;2 devices to
perform apheresis for the collection of plasma to be used as a raw
material for biologically derived pharmaceuticals (also known as
source plasma). Blood center disposables are used with our MCS+
device to collect one or more blood components (principally
platelets but also red cells and plasma) for transfusion to
patients. The Hospital business consists of disposables used with
our Cell Saver&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"&gt;&amp;#xAE;&lt;/sup&gt; and
cardioPAT&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"&gt;&amp;#xAE;&lt;/sup&gt; devices to
recover red cells from blood lost in a surgical procedure so that
these may be made available for reinfusion to the patient
(&amp;#x201C;autotransfusion&amp;#x201D;). OrthoPAT&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"&gt;&amp;#xAE;&lt;/sup&gt; disposables
are used for autotransfusion during and immediately following
orthopedic surgeries. Diagnostics products principally reflect
sales of diagnostic reagents and the TEG&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"&gt;&amp;#xAE;&lt;/sup&gt;
Thrombelastograph&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"&gt;&amp;#xAE;&lt;/sup&gt; hemostasis
analyzer which profiles a patient&amp;#x2019;s blood clotting
characteristics.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Software
solutions include information technology platforms that assist
blood centers, plasma centers, and hospitals to more effectively
manage regulatory compliance and operational efficiency.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
Revenues from External Customers:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Disposable
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Plasma
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;62,759&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;55,917&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Blood center
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;Platelet&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;37,310&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;36,317&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;Red cell&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,869&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,314&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;49,178&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;47,631&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Hospital
disposables&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;Surgical&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;15,742&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,351&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;OrthoPAT&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;7,754&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;8,957&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 45px"&gt;
Diagnostics&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5,615&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,708&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;29,111&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;30,016&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Disposables
revenue&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;141,048&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;133,564&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Software
solutions&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;18,160&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;16,460&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Equipment &amp;amp;
other&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;11,361&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;13,015&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
revenues&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,569&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;163,039&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="pure" decimals="4">0.0165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">27131000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="shares" decimals="INF">41067</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">18945000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;3.
EARNINGS PER SHARE (&amp;#x201C;EPS&amp;#x201D;)&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table provides a reconciliation of the numerators and
denominators of the basic and diluted earnings per share
computations. Basic EPS is computed by dividing net income by
weighted average shares outstanding. Diluted EPS includes the
effect of potentially dilutive common shares.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;For the Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands,
except per share amounts)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Basic
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;16,947&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;17,918&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Weighted average
shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,731&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,140&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic income per
share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.66&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.71&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Diluted
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;16,947&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;17,918&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,731&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,140&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net effect of
common stock equivalents&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;485&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;26,216&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,703&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted income
per share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.65&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.70&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Weighted
average shares outstanding, assuming dilution, excludes the impact
of 0.5&amp;#xA0;million and 1.0 million stock options for the first
quarter of fiscal year 2012 and 2011, respectively, because these
securities were anti-dilutive during the noted periods.&lt;/div&gt;
&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">1849000</us-gaap:EmployeeStockOwnershipPlanESOPCashContributionsToESOP>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">23693000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">2401000</us-gaap:ShareBasedCompensation>
  <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;A
summary of the components of other comprehensive income is as
follows:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;For the three months ended&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;July 2, 2011&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;July 3, 2010&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;16,947&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;17,918&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
comprehensive income:&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net change in
minimum pension liability, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(21&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(49&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Foreign currency
translation&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,705&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(4,247&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Unrealized
gain/(loss) on cash flow hedges, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(1,323&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;450&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
Reclassifications into earnings of cash flow hedge (gains)/losses,
net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,637&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(31&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
comprehensive income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;18,945&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;14,041&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
  <us-gaap:BasisOfAccounting contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;1.
BASIS OF PRESENTATION&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Our
accompanying unaudited consolidated financial statements have been
prepared in accordance with generally accepted accounting
principles (&amp;#x201C;GAAP&amp;#x201D;) in the United States for interim
financial information and with the instructions to Form 10-Q and
Article&amp;#xA0;10 of Regulation&amp;#xA0;S-X. Accordingly, they do not
include all of the information and footnotes required by GAAP for
complete financial statements. In the opinion of our management,
all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included.
All significant intercompany transactions have been eliminated.
Certain reclassifications were made to prior year balances to
conform with the presentation of the financial statements for the
three months ended July&amp;#xA0;2, 2011. Operating results for the
three month period ended July&amp;#xA0;2, 2011 are not necessarily
indicative of the results that may be expected for the full fiscal
year ending March&amp;#xA0;31, 2012, or any other interim period. These
unaudited consolidated financial statements should be read in
conjunction with our audited consolidated financial statements and
footnotes included in our annual report on Form 10-K for the fiscal
year ended April&amp;#xA0;2, 2011.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
Company considers events or transactions that occur after the
balance sheet date but prior to the issuance of the financial
statements to provide additional evidence relative to certain
estimates or to identify matters that require additional
disclosure. Subsequent events have been evaluated, and these
financial statements reflect those material items that arose after
the balance sheet date but prior to the issuance of the financial
statements that would be considered recognized subsequent events.
There were no material recognized subsequent events recorded in the
July&amp;#xA0;2, 2011 consolidated financial statements.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;Our
fiscal year ends on the Saturday closest to the last day of March.
Fiscal year 2012 and 2011 include 52&amp;#xA0;weeks with all four
quarters each having 13&amp;#xA0;weeks.&lt;/div&gt;
&lt;/div&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD_per_shares" decimals="2">0.65</us-gaap:EarningsPerShareDiluted>
  <us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following table provides a reconciliation of the numerators and
denominators of the basic and diluted earnings per share
computations. Basic EPS is computed by dividing net income by
weighted average shares outstanding. Diluted EPS includes the
effect of potentially dilutive common shares.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;For the Three Months Ended&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands,
except per share amounts)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Basic
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;16,947&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;17,918&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Weighted average
shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,731&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,140&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic income per
share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.66&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.71&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Diluted
EPS&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;16,947&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;17,918&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Basic weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,731&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,140&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net effect of
common stock equivalents&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;485&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted weighted
average shares&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;26,216&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;25,703&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Diluted income
per share&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.65&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;0.70&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareReconciliationTableTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-7900000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncomeTaxesPaidNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">1387000</us-gaap:IncomeTaxesPaidNet>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-56000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:InterestExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">106000</us-gaap:InterestExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-1323000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following summarizes the restructuring activity for the three
months ended July&amp;#xA0;2, 2011 and July&amp;#xA0;3, 2010,
respectively:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="40%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;(Dollars in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" colspan="18" nowrap="nowrap" align="center"&gt;Three Months Ended July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Asset&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Write down&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,782&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;137&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,436&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,483&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Facility related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;889&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;200&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(342&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;747&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,671&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;337&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,778&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,230&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="40%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;(Dollars in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" colspan="18" nowrap="nowrap" align="center"&gt;Three Months Ended July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Asset&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Write down&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,245&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,899&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;8,107&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,245&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,899&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;8,107&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
  <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;The
following tables present the fair value of our derivative
instruments as they appear in our consolidated balance sheet as of
July&amp;#xA0;2, 2011 and April&amp;#xA0;2, 2011 by type of contract and
whether it is a qualifying hedge under ASC Topic 815.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="64%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Location in&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance as of&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Balance Sheet&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Assets:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other current
assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,563&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;2,475&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;2,563&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&lt;b&gt;Derivative
Liabilities:&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Designated
foreign currency hedge contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other accrued
liabilities&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;4,174&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;3,707&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&lt;b&gt;4,174&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">361000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;6.
COMPREHENSIVE INCOME&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Comprehensive income is the total of net income and all other
non-owner changes in stockholders&amp;#x2019; equity. Other non-owner
changes are primarily foreign currency translation, the change in
our net minimum pension liability, and the changes in fair value of
the effective portion of our outstanding cash flow hedge
contracts.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;A
summary of the components of other comprehensive income is as
follows:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;For the three months ended&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;July 2, 2011&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;&lt;b&gt;July 3, 2010&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;16,947&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;17,918&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
comprehensive income:&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Net change in
minimum pension liability, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(21&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(49&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Foreign currency
translation&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,705&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(4,247&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Unrealized
gain/(loss) on cash flow hedges, net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(1,323&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;450&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
Reclassifications into earnings of cash flow hedge (gains)/losses,
net of tax&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1,637&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(31&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Total
comprehensive income&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;18,945&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;14,041&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD_per_shares" decimals="2">17.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:NetIncomeLoss contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">16947000</us-gaap:NetIncomeLoss>
  <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
estimate our potential warranty expense based on our historical
warranty experience, and we periodically assess the adequacy of our
warranty accrual and make adjustments as necessary.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="6" nowrap="nowrap" align="center"&gt;&lt;b&gt;For the three months ended&lt;/b&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the beginning of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,273&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;903&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
provision&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;278&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;435&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty
spending&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(292&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(459&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Warranty accrual
as of the end of the period&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,259&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;879&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">337000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">8609000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">313000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-89000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-5">2400000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="shares" decimals="-5">500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
table below provides a reconciliation of the beginning and ending
Level 3 liabilities for the three months ended July 2, 2011.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="88%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Fair Value&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Measurements&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Using
Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Unobservable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;(Level 3)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Beginning
balance&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,284&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Accretion of
interest expense on contingent consideration&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;89&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Change in
value&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(35&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Ending
balance&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">278000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">11801000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD_per_shares" decimals="2">0.66</us-gaap:EarningsPerShareBasic>
  <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;b&gt;13&lt;/b&gt;&lt;font style="FONT-VARIANT: small-caps"&gt;&lt;b&gt;.
REORGANIZATION&lt;/b&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;On
April&amp;#xA0;1, 2010, our Board of Directors approved transformation
and restructuring plans, which primarily include the integration of
Global Med Technologies, Inc. for the periods presented.&lt;/div&gt;
&lt;/div&gt;
&lt;div style="FONT-FAMILY: &apos;Times New Roman&apos;,Times,serif"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
following summarizes the restructuring activity for the three
months ended July&amp;#xA0;2, 2011 and July&amp;#xA0;3, 2010,
respectively:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="40%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;(Dollars in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" colspan="18" nowrap="nowrap" align="center"&gt;Three Months Ended July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Asset&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Write down&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,782&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;137&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,436&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,483&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Facility related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;889&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;200&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;(342&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;747&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,671&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;337&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(1,778&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,230&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="40%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;(Dollars in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" colspan="18" nowrap="nowrap" align="center"&gt;Three Months Ended July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Restructuring&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Accrual&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Asset&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="2" nowrap="nowrap" align="center"&gt;Balance at&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Cost Incurred&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Payments&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;Write down&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Employee-related
costs&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,245&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,899&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;8,107&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;9,761&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;1,245&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;(2,899&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;8,107&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">11988000</us-gaap:DepreciationAndAmortization>
  <us-gaap:TaxBenefitFromStockOptionsExercised contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">356000</us-gaap:TaxBenefitFromStockOptionsExercised>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">23908000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestPaidNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">102000</us-gaap:InterestPaidNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">170569000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-9000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <us-gaap:InventoryDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;7.
INVENTORIES&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Inventories are stated at the lower of cost or market and include
the cost of material, labor and manufacturing overhead. Cost is
determined on the first-in, first-out method.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Raw
materials&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,368&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;26,404&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
Work-in-process&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5,195&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,352&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Finished
goods&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;59,397&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;53,631&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;94,960&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;84,387&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
  <us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">21000</us-gaap:OtherComprehensiveIncomeMinimumPensionLiabilityNetAdjustmentNetOfTax>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
assumptions utilized for stock option grants during the periods
presented are as follows:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="7" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Stock Options
Black-Scholes assumptions (weighted average):&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Volatility&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27.20&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;28.34&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Expected life
(years)&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4.9&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5.0&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Risk-free
interest rate&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1.65&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2.64&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Dividend
yield&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-5">700000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
  <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-7993000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="Year" decimals="1">4.9</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm>
  <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">3059000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
  <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">56231000</us-gaap:SellingGeneralAndAdministrativeExpense>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">6746000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Inventories are stated at the lower of cost or market and include
the cost of material, labor and manufacturing overhead. Cost is
determined on the first-in, first-out method.&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="2" nowrap="nowrap" align="center"&gt;April 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="6" nowrap="nowrap" align="center"&gt;(in thousands)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Raw
materials&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;30,368&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;26,404&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
Work-in-process&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5,195&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4,352&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Finished
goods&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;59,397&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;53,631&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;94,960&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="left"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;84,387&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="2" nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">20184000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="shares" decimals="-3">25731000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">368000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="pure" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;10.
INCOME TAXES&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
Company&amp;#x2019;s reported tax rate was 28.5% for the three month
period ended July 2, 2011, and 26.5% for the three month period
ended July 3, 2010. Our reported tax rate is lower than the federal
statutory tax rate in both periods reported primarily due to lower
foreign tax rates, including tax benefits associated with our Swiss
operations. The reported tax rate was higher for the three months
ended July 2, 2011 as compared to the prior year primarily due to a
$0.8 million benefit recorded during the three months ended July 3,
2010 from the release of a foreign reserve as a result of a foreign
jurisdictional ruling.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;We
conduct business globally and, as a result, file consolidated
federal, consolidated and separate state and foreign income tax
returns in multiple jurisdictions. In the normal course of
business, we are subject to examination by taxing authorities
throughout the world in jurisdictions including the U.S., Japan,
Germany, France, the United Kingdom, and Switzerland. With few
exceptions, we are no longer subject to U.S. federal, state and
local, or foreign income tax examinations for years before
2007.&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-1637000</us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax>
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;8.
ACQUISITIONS&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;b&gt;&lt;i&gt;ACCS Acquisition&lt;/i&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;On
December&amp;#xA0;28, 2010, Haemonetics acquired certain assets of
Applied Critical Care Services, Inc. (ACCS)&amp;#xA0;for
$6.4&amp;#xA0;million. This transaction was&amp;#xA0;accounted for as an
acquisition of a business. ACCS was a manufacturer&amp;#x2019;s
representative for Haemonetics engaged in the selling and servicing
of the TEG product line. The purchase price allocation, which was
finalized during the three months ended July&amp;#xA0;2, 2011, was as
follows: $4.3&amp;#xA0;million in customer relationships;
$0.6&amp;#xA0;million of other liabilities; and $2.7&amp;#xA0;million in
goodwill.&lt;/div&gt;
&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:IncreaseDecreaseInInventories contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">10288000</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:OperatingExpenses contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">64840000</us-gaap:OperatingExpenses>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;4.
STOCK-BASED COMPENSATION&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Stock-based compensation expense of $2.4&amp;#xA0;million and
$2.2&amp;#xA0;million was recognized for the three months ended
July&amp;#xA0;2, 2011 and July&amp;#xA0;3, 2010, respectively. The related
income tax benefit recognized was $0.7&amp;#xA0;million and
$0.5&amp;#xA0;million for the three months ended July&amp;#xA0;2, 2011 and
July&amp;#xA0;3, 2010, respectively.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
weighted average fair value for stock options granted in the first
three months of fiscal year 2012 and 2011 was $17.68 and $17.48,
respectively. The assumptions utilized for stock option grants
during the periods presented are as follows:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="76%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="3%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="7" nowrap="nowrap" align="center"&gt;Three Months Ended&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;July 2, 2011&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;July 3, 2010&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Stock Options
Black-Scholes assumptions (weighted average):&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Volatility&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;27.20&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;28.34&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Expected life
(years)&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;4.9&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;5.0&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Risk-free
interest rate&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;1.65&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2.64&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 30px"&gt;Dividend
yield&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td nowrap="nowrap" align="right"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;0.00&lt;/td&gt;
&lt;td nowrap="nowrap"&gt;%&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;During
the three months ended July&amp;#xA0;2, 2011 and July&amp;#xA0;3, 2010,
there were 41,067 and 35,992 shares purchased under the ESPP,
respectively. They were purchased at $46.80 and $45.70 per share
under the ESPP, respectively.&lt;/div&gt;
&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="pure" decimals="3">0.285</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:UnrealizedGainLossOnDerivatives contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">-609000</us-gaap:UnrealizedGainLossOnDerivatives>
  <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;14.
CAPITALIZATION OF SOFTWARE DEVELOPMENT COSTS&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;For
costs incurred related to the development of software to be sold,
leased, or otherwise marketed, the Company applies the provisions
of ASC Topic 985-20, &lt;i&gt;Software&lt;/i&gt;, which specifies that costs
incurred internally in researching and developing a computer
software product should be charged to expense until technological
feasibility has been established for the product. Once
technological feasibility is established, all software costs should
be capitalized until the product is available for general release
to customers.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;The
Company capitalized $1.5&amp;#xA0;million and $1.2&amp;#xA0;million in
other software development costs for ongoing initiatives during
three month period ended July&amp;#xA0;2, 2011 and July&amp;#xA0;3, 2010,
respectively. At July&amp;#xA0;2, 2011 and April&amp;#xA0;2, 2011, we have
a total of $10.8&amp;#xA0;million and $13.4&amp;#xA0;million, respectively,
of costs capitalized related to in process software development
initiatives, respectively. During the first quarter of fiscal year
2012, $4.1&amp;#xA0;million of capitalized costs related to one project
were placed into service. The costs capitalized for each project
are included in intangible assets in the consolidated financial
statements.&lt;/div&gt;
&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="shares" decimals="-3">26216000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">4467000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;
Financial assets and financial liabilities measured at fair value
on a recurring basis consist of the following as of July&amp;#xA0;2,
2011:&lt;/div&gt;
&lt;div align="center"&gt;
&lt;table style="FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"&gt;
&lt;tr valign="bottom"&gt;
&lt;td width="36%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="1%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td width="5%"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Quoted Market&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Other&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Significant&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Prices for&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Observable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Unobservable&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Identical
Assets&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;Inputs&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td colspan="3" nowrap="nowrap" align="center"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 8pt" valign="bottom"&gt;
&lt;td style="BORDER-BOTTOM: #000000 0px solid" nowrap="nowrap" align="left"&gt;&lt;i&gt;(in thousands)&lt;/i&gt;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;(Level 1)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;(Level 2)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;(Level 3)&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM: #000000 1px solid" colspan="3" nowrap="nowrap" align="center"&gt;Total&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Assets&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Money market
funds&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,823&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,823&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Forward currency
exchange contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;170,823&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,475&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;173,298&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;
&lt;b&gt;Liabilities&lt;/b&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Forward currency
exchange contracts&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="BACKGROUND: #cceeff" valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;Other
liabilities &amp;#x2014; contingent consideration&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 1px solid" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr valign="bottom"&gt;
&lt;td&gt;
&lt;div style="TEXT-INDENT: -15px; MARGIN-LEFT: 15px"&gt;&amp;#xA0;&lt;/div&gt;
&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;&amp;#x2014;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;3,707&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;2,338&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td align="right"&gt;$&lt;/td&gt;
&lt;td align="right"&gt;6,045&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="FONT-SIZE: 1px"&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td&gt;&amp;#xA0;&lt;/td&gt;
&lt;td style="BORDER-TOP: #000000 3px double" colspan="15" align="left"&gt;&amp;#xA0;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">1778000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="pure" decimals="4">0.2720</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="shares" decimals="-3">485000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
  <hae:TransfersFromInventoryToFixedAssets contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD" decimals="-3">3150000</hae:TransfersFromInventoryToFixedAssets>
  <hae:NewAccountingPronouncementsAndChangesInAccountingPrinciplesDisclosureTextBlock contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0">&lt;div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;&lt;b&gt;2.
NEW ACCOUNTING PRONOUNCEMENTS&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;In
May&amp;#xA0;2011, the FASB issued Accounting Standards Update
No.&amp;#xA0;2011-04, &lt;i&gt;Fair Value Measurement (Topic 820): Amendments
to Achieve Common Fair Value Measurement and Disclosure
Requirements in U.S. GAAP and IFRSs.&lt;/i&gt; Update No.&amp;#xA0;2011-04
updates the accounting guidance related to fair value measurements
that results in a consistent definition of fair value and common
requirements for measurement of and disclosure about fair value
between U.S. GAAP and International Financial Reporting Standards
(IFRS). The updated guidance is effective for interim and annual
periods beginning after December&amp;#xA0;15, 2011. Early application
is not permitted. We are currently evaluating the potential impact
of Update No. 2011-04 on our consolidated financial statements.
This statement is effective for our fourth quarter of fiscal year
2012.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;In
June&amp;#xA0;2011, the FASB issued Accounting Standards Update
No.&amp;#xA0;2011-05, &lt;i&gt;Comprehensive Income (Topic 220): Presentation
of Comprehensive Income&lt;/i&gt;. Update No.&amp;#xA0;2011-05 updates the
disclosure requirements for comprehensive income to include total
of comprehensive income, the components of net income, and the
components of other comprehensive income either in a single
continuous statement of comprehensive income or in two separate but
consecutive statements. The updated guidance does not affect how
earnings per share is calculated or presented. The updated guidance
is effective for fiscal years, and interim periods within those
years, beginning after December&amp;#xA0;15, 2011, and should be
applied retrospectively. Early adoption is permitted and amendments
do not require any transition disclosures. This statement is
effective in our first quarter of fiscal year 2013.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 12pt; FONT-SIZE: 10pt" align="left"&gt;
&lt;b&gt;&lt;i&gt;Standards Implemented&lt;/i&gt;&lt;/b&gt;&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;In
October&amp;#xA0;2009, the FASB issued Accounting Standards Update
No.&amp;#xA0;2009-13, &lt;i&gt;Revenue Recognition (Topic 605):
Multiple-Deliverable Revenue Arrangements&lt;/i&gt;, and Accounting
Standards Update No. 2009-14, &lt;i&gt;Software (Topic 985): Certain
Revenue Arrangements That Include Software&lt;/i&gt; (the
&amp;#x201C;Updates&amp;#x201D;). The Updates provide guidance on
arrangements that include software elements, including tangible
products that have software components that are essential to the
functionality of the tangible product and will no longer be within
the scope of the software revenue recognition guidance, and
software-enabled products that will now be subject to other
relevant revenue recognition guidance. The Updates also provide
authoritative guidance on revenue arrangements with multiple
deliverables that are outside the scope of the software revenue
recognition guidance. Under the new guidance, when vendor specific
objective evidence or third party evidence of fair value for
deliverables in an arrangement cannot be determined, a best
estimate of the selling price is required to allocate arrangement
consideration using the relative selling price method. The Updates
also include new disclosure requirements on how the application of
the relative selling price method affects the timing and amount of
revenue recognition. On April&amp;#xA0;3, 2011, the Company adopted
this guidance, which did not have a material impact on our
financial position and results of operations.&lt;/div&gt;
&lt;div style="MARGIN-TOP: 6pt; FONT-SIZE: 10pt" align="left"&gt;In
December&amp;#xA0;2010, the FASB issued Accounting Standards Update
No.&amp;#xA0;2010-29, &lt;i&gt;Business Combinations (Topic 805): Disclosure
of Supplementary Pro Forma Information for Business
Combinations&lt;/i&gt;. Update No.&amp;#xA0;2010-29 clarifies paragraph
805-10-50-2(h) to require public entities that enter into business
combinations that are material on an individual or aggregate basis
to disclose pro forma information for such business combinations
that occurred in the current reporting period, including pro forma
revenue and earnings of the combined entity as though the
acquisition date had been as of the beginning of the comparable
prior annual reporting period only. We did not complete any
material business acquisitions during the three months ended
July&amp;#xA0;2, 2011 thus the disclosure requirements were not
applicable for the period.&lt;/div&gt;
&lt;/div&gt;</hae:NewAccountingPronouncementsAndChangesInAccountingPrinciplesDisclosureTextBlock>
  <hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0" unitRef="iso4217_USD_per_shares" decimals="2">46.80</hae:StockIssuedDuringPeriodEmployeeStockPurchasePlansPricePerShare>
  <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_446729x454321_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-3" id="fnid_24337106_1001_1">-41000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_446729x478703_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-3">-1323000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_446729x478703_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-3">-1637000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:CashFlowHedgeLossReclassifiedToEarnings contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-5">600000</us-gaap:CashFlowHedgeLossReclassifiedToEarnings>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x450145" unitRef="iso4217_USD" decimals="-3">141048000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x472622" unitRef="iso4217_USD" decimals="-3">11361000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478709" unitRef="iso4217_USD" decimals="-3">62759000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478711" unitRef="iso4217_USD" decimals="-3">49178000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478711_456277x478706" unitRef="iso4217_USD" decimals="-3">37310000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478711_456277x478707" unitRef="iso4217_USD" decimals="-3">11869000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712" unitRef="iso4217_USD" decimals="-3">29111000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712_456277x478708" unitRef="iso4217_USD" decimals="-3">15742000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712_456277x478714" unitRef="iso4217_USD" decimals="-3">5615000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712_456277x478715" unitRef="iso4217_USD" decimals="-3">7754000</us-gaap:SalesRevenueGoodsNet>
  <us-gaap:SalesRevenueGoodsNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478713" unitRef="iso4217_USD" decimals="-3">18160000</us-gaap:SalesRevenueGoodsNet>
  <hae:PercentageOfNetSales contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_446310x453298" unitRef="pure" decimals="2">0.49</hae:PercentageOfNetSales>
  <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_446729x454493_449485x445999_451532x449846" unitRef="iso4217_USD" decimals="-3" id="fnid_24337106_1002_1">591000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_449485x455587" unitRef="iso4217_USD" decimals="-5">1600000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_449485x455587_451532x449846" unitRef="iso4217_USD" decimals="-5">1300000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">-35000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
  <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450407x454319" unitRef="iso4217_USD" decimals="-3">89000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x445456" unitRef="iso4217_USD" decimals="-3">137000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x445456" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x445456" unitRef="iso4217_USD" decimals="-3">1436000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:RestructuringReservePeriodExpense contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x447194" unitRef="iso4217_USD" decimals="-3">200000</us-gaap:RestructuringReservePeriodExpense>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x447194" unitRef="iso4217_USD" xsi:nil="true" />
  <us-gaap:RestructuringReserveSettledWithCash contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x447194" unitRef="iso4217_USD" decimals="-3">342000</us-gaap:RestructuringReserveSettledWithCash>
  <us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_451532x449846" unitRef="iso4217_USD" decimals="-3" id="fnid_24337106_1003_1">550000</us-gaap:GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_451532x449846" unitRef="iso4217_USD" decimals="-3">-1323000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet contextRef="eol_PE5753----1110-Q0006_STD_91_20110702_0_451532x449846" unitRef="iso4217_USD" decimals="-3">-1637000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x447194">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_450407x454319">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_449485x455587">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_446729x454493_449485x445999_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_446310x453298">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:SoftwareSolutionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712_456277x478715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:OrthopatMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712_456277x478714">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712_456277x478708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:SurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478712">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478711_456277x478707">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:RedCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478711_456277x478706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:PlateletMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x478709">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x472622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:EquipmentAndOtherRelatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_442428x450145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_446729x478703_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">hae:NetRevenuesCostOfGoodsSoldAndSellingGeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0_441306x451457_446729x454321_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByIncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20110702_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2011-04-03</startDate>
      <endDate>2011-07-02</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478713">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:SoftwareSolutionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712_456277x478715">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:OrthopatMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712_456277x478714">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712_456277x478708">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:SurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478712">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:HospitalDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478711_456277x478707">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:RedCellMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478711_456277x478706">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">hae:PlateletMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478711">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:BloodBankDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x478709">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:PlasmaDisposablesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x472622">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hae:EquipmentAndOtherRelatedMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_442428x450145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0_441306x451457_449485x455587_451532x449846">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_91_20100703_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <startDate>2010-04-04</startDate>
      <endDate>2010-07-03</endDate>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110402_0_450737x447194">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110402_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110402_0_450407x454319">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110402_0_441306x451457_451532x449846_452742x468536">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherAccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110402_0_441306x451457_451532x449846_452742x467802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherCurrentAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110402_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2011-04-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20100403_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-04-03</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20100403_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2010-04-03</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_452537x478695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:AppliedCriticalCareServicesIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_450737x447194">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x454206">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x452604">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319_453639x441954">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_450407x454319">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_441306x451457_451532x449846_452742x468536">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherAccruedLiabilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0_441306x451457_451532x449846_452742x467802">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativesFairValueByBalanceSheetLocationAxis">hae:OtherCurrentAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20110702_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2011-07-02</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20101228_0_452537x478695">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hae:AppliedCriticalCareServicesIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-12-28</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20100703_0_450737x445456">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2010-07-03</instant>
    </period>
  </context>
  <context id="eol_PE5753----1110-Q0006_STD_0_20100703_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000313143</identifier>
    </entity>
    <period>
      <instant>2010-07-03</instant>
    </period>
  </context>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Year">
    <measure>hae:Year</measure>
  </unit>
  <xbrll:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <xbrll:loc xlink:href="#fnid_24337065_1_10" xlink:label="fnid_24337065_1_10" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_11" xlink:label="fnid_24337065_1_11" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_12" xlink:label="fnid_24337065_1_12" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_13" xlink:label="fnid_24337065_1_13" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_14" xlink:label="fnid_24337065_1_14" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_15" xlink:label="fnid_24337065_1_15" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_16" xlink:label="fnid_24337065_1_16" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_18" xlink:label="fnid_24337065_1_18" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_19" xlink:label="fnid_24337065_1_19" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_2" xlink:label="fnid_24337065_1_2" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_20" xlink:label="fnid_24337065_1_20" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_21" xlink:label="fnid_24337065_1_21" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_22" xlink:label="fnid_24337065_1_22" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_23" xlink:label="fnid_24337065_1_23" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_24" xlink:label="fnid_24337065_1_24" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_27" xlink:label="fnid_24337065_1_27" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_28" xlink:label="fnid_24337065_1_28" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_29" xlink:label="fnid_24337065_1_29" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_3" xlink:label="fnid_24337065_1_3" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_30" xlink:label="fnid_24337065_1_30" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_31" xlink:label="fnid_24337065_1_31" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_32" xlink:label="fnid_24337065_1_32" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_33" xlink:label="fnid_24337065_1_33" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_34" xlink:label="fnid_24337065_1_34" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_35" xlink:label="fnid_24337065_1_35" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_36" xlink:label="fnid_24337065_1_36" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_37" xlink:label="fnid_24337065_1_37" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_39" xlink:label="fnid_24337065_1_39" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_4" xlink:label="fnid_24337065_1_4" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_40" xlink:label="fnid_24337065_1_40" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_41" xlink:label="fnid_24337065_1_41" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_42" xlink:label="fnid_24337065_1_42" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_43" xlink:label="fnid_24337065_1_43" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_44" xlink:label="fnid_24337065_1_44" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_45" xlink:label="fnid_24337065_1_45" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_46" xlink:label="fnid_24337065_1_46" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_47" xlink:label="fnid_24337065_1_47" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_48" xlink:label="fnid_24337065_1_48" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_5" xlink:label="fnid_24337065_1_5" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_6" xlink:label="fnid_24337065_1_6" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_7" xlink:label="fnid_24337065_1_7" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337065_1_8" xlink:label="fnid_24337065_1_8" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337106_1001_1" xlink:label="fnid_24337106_1001_1" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337106_1002_1" xlink:label="fnid_24337106_1002_1" xlink:type="locator"/>
    <xbrll:loc xlink:href="#fnid_24337106_1003_1" xlink:label="fnid_24337106_1003_1" xlink:type="locator"/>
    <xbrll:footnote xlink:label="footnote_24337081" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">We exclude the difference between the spot rate and hedge forward rate from our effectiveness testing.</xbrll:footnote>
    <xbrll:footnote xlink:label="footnote_24337082" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(Unaudited)</xbrll:footnote>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_10" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_11" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_12" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_13" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_14" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_15" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_16" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_18" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_19" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_2" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_20" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_21" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_22" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_23" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_24" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_27" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_28" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_29" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_3" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_30" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_31" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_32" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_33" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_34" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_35" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_36" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_37" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_39" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_4" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_40" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_41" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_42" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_43" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_44" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_45" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_46" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_47" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_48" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_5" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_6" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_7" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337065_1_8" xlink:to="footnote_24337082" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337106_1001_1" xlink:to="footnote_24337081" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337106_1002_1" xlink:to="footnote_24337081" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
    <xbrll:footnoteArc xlink:from="fnid_24337106_1003_1" xlink:to="footnote_24337081" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" order="1.0" xlink:type="arc"/>
  </xbrll:footnoteLink>
</xbrl>
</XBRL>
